128 results
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
IDSA Recommendations ... for Preventing ... PO (or 400 mg IV ... PO (or 400 mg IV ... Enteric #Bacterial #IDSA
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... for Preventing ... Infections in HIV-AIDS Preventing ... to 5 mg/kg/day IV ... Penicilliosis #IDSA
Acute ED Migraine Therapy and Preventative Therapy Algorithm:
Acute migraine
 • IV NS IL bolus then infusion
Acute migraine • IV ... • Ketorolac IV ... 20 mg/min -> Neurology ... algorithm #treatment #prevention ... #prophylaxis #neurology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
IDSA Recommendations ... for Preventing ... Preventing First ... HumanPapillomavirus #IDSA ... #Prevention #Treatment
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
IDSA Recommendations ... for Preventing ... ) in HIV-AIDS Preventing ... Trypanosomiasis #IDSA ... #Prevention #Treatment
Parenteral Antimicrobial Treatment of Common Microorganisms Causing Native Vertebral Osteomyelitis - IDSA 
Staphylococci, oxacillin susceptible
Staphylococci, oxacillin
Osteomyelitis - IDSA ... #Parenteral #IV ... #pharmacology #idsa
Differential Algorithm of causes of Acute Urinary Retention 

#Diagnosis #Urology #Urinary #Retention #Algorithm #Differential #Ddxof
Acute Urinary Retention ... #Diagnosis #Urology ... #Urinary #Retention
Urinary Retention and Incontinence - Management Algorithm for Catheterization

#Foley #Catheterization #Urinary #Retention #Incontinence #Management #Algorithm #Urology
Urinary Retention ... Catheterization #Urinary #Retention ... Management #Algorithm #Urology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
IDSA Recommendations ... amphotericin B 2–4 mg/kg IV ... amphotericin B 2–4 mg/kg IV ... stibogluconate) 20 mg/kg IV ... Leishmaniasis #Prevention
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... 400 mg) PO or IV ... candida #mucosal #IDSA ... #Prevention #Treatment